Darzalex
Daratumumab · CD20 / CD38 Targeted Cytolytic Antibody
Indications & Uses
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Contraindications
Hypersensitivity to active ingredient or any formulation excipients.
Side Effects & Warnings
Infusion-related reactions, severe neutropenia, infection risk, hepatitis B reactivation.
Drug & Dietary Interactions
Caution with strong CYP3A inhibitors or inducers; review concurrent medications.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Patient & Caregiver Support
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.